|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| A61K 31/4745 | (2006.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 37/00 | (2006.01) |
| (11) | Number of the document | 2744809 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12748028.3 |
| Date of filing the European patent application | 2012-08-15 | |
| (97) | Date of publication of the European application | 2014-06-25 |
| (45) | Date of publication and mention of the grant of the patent | 2016-10-12 |
| (46) | Date of publication of the claims translation | 2016-12-27 |
| (86) | Number | PCT/EP2012/065918 |
| Date | 2012-08-15 |
| (87) | Number | WO 2013/024104 |
| Date | 2013-02-21 |
| (30) | Number | Date | Country code |
| 201114103 | 2011-08-17 | GB |
| (72) |
DEMONT, Emmanuel, Hubert, GB
JONES, Katherine, Louise, GB
WATSON, Robert J, GB
|
| (73) |
GlaxoSmithKline LLC,
Corporation Service Company 2711 Centerville Road Suite 400, Wilmington DE 19808,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | 4-(8-Metoksi-1-((1-metoksipropan-2-il)-2-(tetrahidro-2H-piran-4-il)-1H-imidazo[4,5-c]chinolin-7-il)-3,5-dimetilizoksazolas ir jo panaudojimas kaip bromodomeno inhibitoriaus |
| 4-(8-METHOXY-1-((1-METHOXYPROPAN-2-YL)-2-(TETRAHYDRO-2H-PYRAN-4-YL)-1 H-IMIDAZO[4,5-C]QUINOLIN-7-YL)-3,5-DIMETHYLISOXAZOLE AND ITS USE AS BROMODOMAIN INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2018-08-06 | 7 | 162.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-08-15 |